BURLINGAME, Calif. (AP) _ Corvus Pharmaceuticals Inc. (CRVS) on Tuesday reported a loss of $11 million in its third quarter.
On a per-share basis, the Burlingame, California-based company said it had a loss of 37 cents.
The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 40 cents per share.
In the final minutes of trading on Tuesday, the company's shares hit $3.54. A year ago, they were trading at $7.30.